Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

about

Novel viral vectors in infectious diseases.Virus-Like-Vaccines against HIV.

P2860

Q40059020-6310F707-D80F-4303-87D2-4FF6C99D17DE Q50034030-F8C75DE5-601D-4AB4-80DB-DE7759B276E4

P2860

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

Item

http://www.wikidata.org/entity/Q38728732

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

@en

type

Item

label

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

@en

prefLabel

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

@en

P1476

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

@en

P275

Creative Commons Attribution

P2860

Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001

Vaccination greatly reduces disease, disability, death and inequity worldwide

Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication

Oral priming with replicating adenovirus serotype 4 followed by subunit H5N1 vaccine boost promotes antibody affinity maturation and expands H5N1 cross-clade neutralization.

Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter.

Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines

Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine

High-capacity adenoviral vectors for gene transfer and somatic gene therapy.

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.

P31

scholarly article

review article

P356

10.3390/IJMS18040686

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Johannes Holst

Cyrielle Fougeroux

P577

2017-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28420073

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

recombinant protein

Añaw

P932

5412272

http://www.w3.org/2001/XMLSchema#string

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

about

P2860

P2860

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

description

name

type

label

prefLabel

P1433

P1476

P275

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P275

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932